In this study, we employed single-cell transcriptomic analysis to gain greater insight into the pathology of CMC than routine clinical tests, to explore potential genes of interest through the analysis of the DEGs of PBMCs, and to more comprehensively characterize the immune response in a CMC patient harboring a STAT1 GOF mutation. This evidence concerns the gene STAT1 and chronic mucocutaneous candidiasis.